Roberta Diaz Brinton, PhD
Roberta Diaz Brinton is the director of the Center for Innovation in Brain Science at the University of Arizona and a professor of pharmacology and neurology at the University of Arizona College of Medicine. Prior, Brinton was a professor of molecular pharmacology, biomedical engineering, and neurology at the University of Southern California, where she directed the Clinical and Translational Science Institute Center for Scientific Translation and Norris Foundation Laboratory for Neuroscience Research. Brinton is internationally recognized as an innovative leader in Alzheimer’s research and development of therapeutics to prevent, delay, and treat the disease. She leads multiple NIH National Institute on Aging grants focused on brain aging and Alzheimer’s disease. Her latest innovation is the development, which is currently in clinical testing, is the first regenerative therapeutic for Alzheimer’s disease. Brinton has published over 200 scientific reports and holds multiple patents targeting Alzheimer’s disease and neurodegenerative diseases. She serves on the boards of the Alzheimer’s Drug Discovery Foundation and NIH Center for Scientific Review. Among her many recognitions, Brinton was awarded the Alzheimer’s Drug Discovery Foundation Scientist of the Year, U.S. News and World Report Ten Best Minds, and the Presidential Citizens Medal.